Home/Filings/4/0001415889-22-012347
4//SEC Filing

Chen Jing 4

Accession 0001415889-22-012347

CIK 0001563665other

Filed

Dec 8, 7:00 PM ET

Accepted

Dec 9, 5:19 PM ET

Size

8.6 KB

Accession

0001415889-22-012347

Insider Transaction Report

Form 4
Period: 2022-12-07
Chen Jing
Director
Transactions
  • Exercise of In-Money

    Common Stock

    2022-12-07$2.00/sh+174,000$348,000210,000 total
  • Sale

    Common Stock

    2022-12-07$7.17/sh48,532$347,974161,468 total
  • Exercise of In-Money

    Warrants (right to buy)

    2022-12-07174,0000 total
    Exercise: $2.00From: 2017-12-27Exp: 2022-12-27Common Stock (174,000 underlying)
Footnotes (1)
  • [F1]On December 7, 2022, the Reporting Person exercised a warrant to purchase 174,000 shares of common stock for $2 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in Biostage's withholding of 48,532 shares to pay the exercise price based on the daily VWAP of $7.1706, and issuing the remaining 125,468 shares of common stock.

Issuer

Biostage, Inc.

CIK 0001563665

Entity typeother

Related Parties

1
  • filerCIK 0001727177

Filing Metadata

Form type
4
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 5:19 PM ET
Size
8.6 KB